MinuteCE®
A robust collection of short-form, digestible CE activities that are made to fit into any schedule. With MinuteCE, you’re in control of the content you want, when you want it. To start microlearning, follow these simple steps:
Step 1: Select the episodes & 1-minute challenges you'd like to consume
Step 2: Bank time as you blaze your way through the program
Step 3: Claim credit once available as shown in the Progress Bar
Step 4: Track the status of credits claimed in your profile
Why choose microlearning?
- Bite-sized episodes
- The most relevant content
- Improved retention
To experience MinuteCE for yourself, select one of the episodes below to start learning!
1-15 of 168
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®SHTG: Decoding the Latest Clinical Trial Outcomes
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®The Road Ahead: What's on the Horizon for FCS and SHTG Management
Pam R. Taub, MD, FACC, FASPC
Prof. Kausik Ray
APOC3 Inhibition: A Novel Approach to Lowering TGs
MinuteCE®APOC3 Inhibition: A Novel Approach to Lowering TGs
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®Remnant Cholesterol: The Missing Link in ASCVD risk
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
- advertisement
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®Targeting Mixed Hyperlipidemia with APOC3 Inhibition
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®Latest Clinical Trial Outcomes and Breakthroughs for FCS
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
Preventing Myasthenic Crisis: Early Signs and Critical Interventions
MinuteCE®Preventing Myasthenic Crisis: Early Signs and Critical Interventions
Vera Bril, MD
Hans Katzberg, MD
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
Vera Bril, MD
Nicholas J. Silvestri, MD
- advertisement
Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
MinuteCE®Traditional MG Treatments: Balancing Benefits, Risks, and Side Effect Management
Vera Bril, MD
Hans Katzberg, MD
Diagnostic Advances in gMG: Effective Tools and Techniques
MinuteCE®Diagnostic Advances in gMG: Effective Tools and Techniques
Vera Bril, MD
Hans Katzberg, MD
Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
MinuteCE®Precision Medicine for gMG: Tailoring Treatments Based on Patient Profiles
Vera Bril, MD
Nicholas J. Silvestri, MD
